Biomarker

Results: 1953



#Item
991Disclaimer: The views expressed in this presentation are the personal views of the speaker and may not be understood or quoted as being made on behalf of or reflecting the position of the EMA or one of its committees or

Disclaimer: The views expressed in this presentation are the personal views of the speaker and may not be understood or quoted as being made on behalf of or reflecting the position of the EMA or one of its committees or

Add to Reading List

Source URL: www.imi.europa.eu

Language: English - Date: 2013-03-11 07:11:06
992Exposing the Criminal Record of Every Blood Sample:  Use of SOMAmer Technology and Sample Mapping Vectors  to Mitigate False Biomarker Discoveries Rachel Ostroff, PhD Clinical Research Director, 

Exposing the Criminal Record of Every Blood Sample:  Use of SOMAmer Technology and Sample Mapping Vectors  to Mitigate False Biomarker Discoveries Rachel Ostroff, PhD Clinical Research Director, 

Add to Reading List

Source URL: biospecimens.cancer.gov

Language: English - Date: 2012-10-23 20:37:07
993Companion Diagnostic Guidance

Companion Diagnostic Guidance

Add to Reading List

Source URL: www.fda.gov

Language: English
994Microsoft PowerPoint - Patterson

Microsoft PowerPoint - Patterson

Add to Reading List

Source URL: biospecimens.cancer.gov

Language: English - Date: 2012-10-23 20:37:13
995Microsoft PowerPoint - 05 Doroshow Revised.ppt [Compatibility Mode]

Microsoft PowerPoint - 05 Doroshow Revised.ppt [Compatibility Mode]

Add to Reading List

Source URL: deainfo.nci.nih.gov

Language: English - Date: 2011-04-19 11:06:33
996Clinical trials / Epidemiology / Medical research / Medical terms / Prodrugs / Biomarker / Irinotecan / Surrogate endpoint / CYP3A4 / Medicine / Chemistry / Health

Topic 1 Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism 1. Is the pharmacokinetic and clinical evidence presented sufficient to demonstrate that homozygous UGT1A1*28 genotypes (7/7 ge

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-10-14 14:44:52
997Fact Sheet The Potential of Personalized Medicine Personalized medicine offers the potential to transform the delivery of medical treatment to patients. The genetic make-up of the individual, the environment and the spec

Fact Sheet The Potential of Personalized Medicine Personalized medicine offers the potential to transform the delivery of medical treatment to patients. The genetic make-up of the individual, the environment and the spec

Add to Reading List

Source URL: www.genomeatlantic.ca

Language: English - Date: 2012-01-31 11:46:34
998Microsoft PowerPoint - deVos

Microsoft PowerPoint - deVos

Add to Reading List

Source URL: biospecimens.cancer.gov

Language: English - Date: 2012-10-23 20:37:13
999Microsoft PowerPoint - Animal Models-How To Jim - O [Read-Only] [Compatibility Mode]

Microsoft PowerPoint - Animal Models-How To Jim - O [Read-Only] [Compatibility Mode]

Add to Reading List

Source URL: www1.va.gov

Language: English - Date: 2014-05-09 16:21:08
1000Topic 1  Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism  1. Is the pharmacokinetic and clinical evidence presented sufficient to

Topic 1 Pharmacogenetics of Irinotecan: Scientific and Clinical Impact of UGT Polymorphism 1. Is the pharmacokinetic and clinical evidence presented sufficient to

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-10-14 14:44:52